Warning: Last items in stock!
Terramycine The skin cream (with polymyxin B sulfate) is indicated for the prevention and treatment of localized skin infections such as pyoderma, pustular dermatitis and mild infections of wounds or burns due to susceptible micro-organisms.
Oxytetracyclini hydrochloridum (oxytetracyclinum = 30mg) - Polymyxini B sulphate (10,000 U = polymyxinum) - Paraffin. liquid. - Vaselinum pro 1 g.
Posology and method of use:
Terramycine The skin cream (with polymyxin B sulfate) is only externally. First the skin is thoroughly cleansed and then the ointment using sterile gauze directly on the affected skin surface. This needs at least two or three times a day repeated.
The local application of cold cream Terramycine (with polymyxin B sulfate) should be supplemented with a general antibiotic treatment along the road when a deep skin infection is concerned.
The ointment in continuous contact with the treatment site. Treatment duration depends on the nature and severity of the infection and can vary from several days to several weeks. Since early discontinuation of treatment the infection can flare recurrence, therapy should be continued until healing is complete.
This is a medicine, no prolonged use without medical advice, store out of reach of children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.
The skin ointment Terramycine (with polymyxin B sulfate) is contraindicated in patients contraindicated for one of its components have shown a hypersensitivity.
As is the case with other antibiotics, the use of skin cream Terramycine lead to super infection by a non-sensitive micro organisms, including fungi. It is therefore essential that the patient remains under constant supervision. If a new infection during treatment by not susceptible bacteria or fungi occurs, an appropriate therapy based on susceptibility tests are established.
Is appointed in addition to the topical application of skin cream Terramycine a systemic treatment should be administered when the Skin infections can be severe or systemic.
use in children.
Systemic administration of tetracyclines during the period of tooth formation (second half of pregnancy, and children under 8 years) can lead to permanent discoloration of the teeth and delayed skeletal development. Cases of hypoplasia of the tooth enamel are also reported. Although these effects are unlikely because of the low doses used, it should be after topical application of tetracyclines to take into account the possibility that these effects occur.
Pregnancy and lactation:
There are no controlled studies on the use of topical tetracyclines in pregnant women. Systemic use of tetracyclines in pregnant women has led to a delayed skeletal ossification and in the fetus. During pregnancy, the drugs of this class is only used if the potential benefit justifies the potential risk.
We do not know whether the local Tetracyclines are excreted in breast . The tetracyclines are indeed in breast milk after systemic administration. Given the potential for serious adverse effects in infants is advisable either to discontinue nursing or to discontinue treatment, taking into account the importance of the drug to the mother.
Allergic reactions, especially contact dermatitis, due to individual hypersensitivity have been reported. If such reactions occur, treatment should be put stop.
driving and using machines:
oxytetracyclinepreparaten externally have theoretically not affect the ability to drive or operate machinery.
No cases of overdose reported with oxytetracyclinebevattende skin ointment.
There is no specific antidote. In case of overdose, it is appropriate to discontinue treatment, to treat the symptoms and supportive treatment to.
|Type of product||Medicine|
Customer ratings and reviews